Results 161 to 170 of about 29,210 (297)

Simulation Model of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) With Prior Treatment

, 2014
Feng Pan, Siyang Peng, S. Sorensen, Emily Dorman, S. Sun, Maren Gaudig, Nishan Sengupta   +6 more
openalex   +1 more source

ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO [PDF]

, 2016
F. Carlos, M. Zurita Herrera, Aníbal Salazar, Andrew J. Aguirre, L González-Michaca   +4 more
openalex   +1 more source

Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration ibrutinib‐venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age‐matched European population

HemaSphere, Volume 9, Issue 10, October 2025.
Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad, Claudio A. Schioppa, José‐Ángel Hernández‐Rivas, Alessandra Tedeschi   +7 more
wiley   +1 more source

Functional characterization of BTKC481S mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors

, 2014
Sijie Cheng, Ailin Guo, Ping Lu, Jiao Ma, Morton Coleman, Y. Lynn Wang   +5 more
openalex   +1 more source

Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia [PDF]

, 2016
Charles L. Bennett, Joseph R. Berger, Oliver Sartor, Kenneth R. Carson, William J.M. Hrushesky, Peter Georgantopoulos, Dennis W. Raisch, LeAnn B. Norris, Jamés O. Armitage   +8 more
openalex   +1 more source

Ibrutinib is an effective treatment for B‐cell prolymphocytic leukaemia [PDF]

, 2016
Max J. Gordon, Philipp W. Raess, Kathleen M. Young, Stephen E. Spurgeon, Alexey V. Danilov   +4 more
openalex   +1 more source

Ibrutinib supercharges CAR T cells [PDF]

, 2016
Peter Sidaway
openalex   +1 more source

Ibrutinib Enhances the Activity of Anti-CD20 Antibodies in an MCL Mouse Model: Effect of Drug at Clinically Relevant Concentrations on ADCC and ADCP

, 2015
Patrick P. Ng, Daniel Lu, Juthamas Sukbuntherng, Jutta K. Neuenburg, Danelle F. James, Betty Chang   +5 more
openalex   +1 more source

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103 [PDF]

, 2016
Chaitra S. Ujjani, Sin‐Ho Jung, Brandelyn N. Pitcher, Peter Martin, Steven I. Park, Kristie A. Blum, Sonali M. Smith, Myron S. Czuczman, Matthew S. Davids, Ellis Levine, Lionel D. Lewis, Scott E. Smith, Nancy L. Bartlett, John P. Leonard, Bruce D. Cheson   +14 more
openalex   +1 more source

Ibrutinib

Reactions Weekly, 2021
openaire   +1 more source